Scientists at the University of Sydney have uncovered a malfunctioning version of the SOD1 protein that clumps inside brain ...

A new study reveals that which side of the body is initially affected by Parkinson's disease can predict cognitive decline ...

Groundbreaking research by Sydney University found a new brain protein involved in Parkinson’s disease and a way to modify it ...

An active ingredient in cough medicines since 1979 has shown promise as a treatment for neuropsychiatric symptoms in ...

Ambroxol, a cough medication, may help stabilize the neuropsychiatric symptoms of Parkinson's disease dementia, a new study ...

New research shows that inhibiting overactive LRRK2 enzymes could stabilize Parkinson's disease progression, with Stanford ...

Parkinson's disease affects approximately 10 million people worldwide. It typically begins asymmetrically, initially ...

Wolff-Parkinson-White Syndrome is a type of arrhythmia that is commonly diagnosed in young people and infants Here’s all you ...

Parkinson's disease occurs when brain cells that produce an important hormone called dopamine begin to die off or become ...

Ambroxol, long used for coughs in Europe, stabilized symptoms and brain-damage markers in Parkinson’s dementia patients over ...

Research at the University of Wisconsin-Eau Claire is now backed by the Mayo Clinic Health System thanks to their collaboration agreement, as students are testing technology that could impact people ...

People with Parkinson’s often stay silent about their diagnosis. Here’s what drives that silence and why understanding it ...